Source: NSW Health
NSW company develops bold new way to attack cancers
Rapidly developing Sydney-based company AdvanCell Isotopes is one of only three companies to receive funding in 2021 from the NSW Health Medical Devices Fund.
Around the world, universities, medical researchers and MedTech companies are striving to find new and better ways to treat cancer. A fast-growing NSW-based company, AdvanCell Isotopes, has developed technology that could change cancer treatments forever with advances occurring in late 2021. The company recently received a $2.1 million grant from the NSW Health Medical Devices Fund.
